BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2859189)

  • 21. Immunohistochemical analysis of the effects of cysteamine on somatostatin-like immunoreactivity in the rat central nervous system.
    Ceccatelli S; Hökfelt T; Hallman H; Nylander I; Terenius L; Elde R; Brownstein M
    Peptides; 1987; 8(2):371-84. PubMed ID: 2884649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin in rat tissues is depleted by cysteamine administration.
    Szabo S; Reichlin S
    Endocrinology; 1981 Dec; 109(6):2255-7. PubMed ID: 6118261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cysteamine on secretion of gastrin and somatostatin from the rat stomach.
    McIntosh C; Bakich V; Trotter T; Kwok YN; Nishimura E; Pederson R; Brown J
    Gastroenterology; 1984 May; 86(5 Pt 1):834-8. PubMed ID: 6142843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cysteamine on pain behaviour and on somatostatin- and substance P-like immunoreactivity in the substantia gelatinosa of the rat.
    Dalsgaard CJ; Vincent SR; Hökfelt T; Wiesenfeld-Hallin Z; Gustafsson L; Elde R; Dockray GJ
    Eur J Pharmacol; 1984 Sep; 104(3-4):295-301. PubMed ID: 6209149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
    Parsons JA; Peterson EK; Hartfel MA
    Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cysteamine administration on the in vivo incorporation of [35S]cysteine into somatostatin-14, somatostatin-28, arginine vasopressin, and oxytocin in rat hypothalamus.
    Cameron JL; Fernstrom JD
    Endocrinology; 1986 Sep; 119(3):1292-7. PubMed ID: 2874017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteamine-induced depletion of somatostatin in sheep: time course of depletion and changes in plasma metabolites, insulin, and growth hormone.
    McLeod KR; Harmon DL; Schillo KK; Mitchell GE
    J Anim Sci; 1995 Jan; 73(1):77-87. PubMed ID: 7601757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cysteamine-induced decrease of somatostatin in rat brain synaptosomes in vitro.
    Widmann R; Sperk G
    Endocrinology; 1987 Oct; 121(4):1383-9. PubMed ID: 2888645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the fate of centrally administered somatostatin in the rat: massive hypersomatostatinemia resulting from leakage into the peripheral circulation has effects on growth hormone secretion and glucoregulation.
    Tannenbaum GS; Patel YC
    Endocrinology; 1986 May; 118(5):2137-43. PubMed ID: 2870913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventromedial hypothalamic somatostatin may affect gastric somatostatin concentration in rats.
    Qu F; Bai B; Zhu HN
    Neuropeptides; 1990 Jun; 16(2):97-101. PubMed ID: 1979157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin depletion by cysteamine: mechanism and implication for duodenal ulceration.
    Szabo S; Reichlin S
    Fed Proc; 1985 Jun; 44(9):2540-5. PubMed ID: 2860015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for selective release of somatostatin-14 and somatostatin-28(1-12) from rat hypothalamus.
    Bakhit C; Koda L; Benoit R; Morrison JH; Bloom FE
    J Neurosci; 1984 Feb; 4(2):411-9. PubMed ID: 6142098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cysteamine on the hypothalamic-pituitary axis in the rat.
    McComb DJ; Cairns PD; Kovacs K; Szabo S
    Fed Proc; 1985 Jun; 44(9):2551-5. PubMed ID: 2860017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic production of somatostatin-like immuno- and bioactivity by cultured human pulmonary small cell carcinoma.
    Szabo M; Berelowitz M; Pettengill OS; Sorenson GD; Frohman LA
    J Clin Endocrinol Metab; 1980 Nov; 51(5):978-87. PubMed ID: 6106652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of local injection of cysteamine and cystamine on somatostatin and neuropeptide Y levels in the rat striatum.
    Widmann R; Maas D; Sperk G
    J Neurochem; 1988 Jun; 50(6):1682-6. PubMed ID: 2897423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin metabolism by the isolated rat lung.
    Ruggere MD; Patel YC
    Endocrinology; 1985 Nov; 117(5):1870-3. PubMed ID: 2864236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical evaluation of cysteamine as a tool to deplete somatostatin in the rat central nervous system.
    Cook LL; Bissette G; Dole K; Nemeroff CB
    Endocrinology; 1989 Feb; 124(2):855-61. PubMed ID: 2563244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement and characterization of somatostatin-14-like immunoreactivity in human urine.
    Rabbani SN; Patel YC
    J Clin Endocrinol Metab; 1988 May; 66(5):1050-5. PubMed ID: 2896203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin.
    Schettini G; Florio T; Magri G; Grimaldi M; Meucci O; Landolfi E; Marino A
    Eur J Pharmacol; 1988 Jul; 151(3):399-407. PubMed ID: 2905659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.